VisaThera Research Private Limited
VisaThera Research translates natural product and marine bioactive science into early-stage drug candidates for unmet medical needs. It combines hybrid pharmacophore modelling, multi-omics analytics, molecular simulations, and experimental biology to enable discovery and validation. The company focuses on small-molecule drug discovery, enzyme inhibition studies, probiotic-integrated formulations, in vitro assays, and AI-enabled lead optimization as part of its core capabilities. It provides computational services, formulation development, and contract research support to academic institutions, biotech startups, and industry partners. As a translational research-focused organization, VisaThera aims to accelerate idea-to-product progress and scale across India and global collaborations.
VisaThera Research Private Limited
VisaThera Research translates natural product and marine bioactive science into early-stage drug candidates for unmet medical needs. It combines hybrid pharmacophore modelling, multi-omics analytics, molecular simulations, and experimental biology to enable discovery and validation. The company focuses on small-molecule drug discovery, enzyme inhibition studies, probiotic-integrated formulations, in vitro assays, and AI-enabled lead optimization as part of its core capabilities. It provides computational services, formulation development, and contract research support to academic institutions, biotech startups, and industry partners. As a translational research-focused organization, VisaThera aims to accelerate idea-to-product progress and scale across India and global collaborations.